Regulatory approval could push Axa’s sale of Indian business into 2022: Jefferies
French insurer Axa’s planned sale of its interest in Indian carrier Bharti Axa GI to ICICI Lombard – in a deal valued at Eur521mn ($615.2mn) – could be delayed until 2022 as a result of the regulatory approval required, Jefferies analysts have said.
If you are a subscriber, please sign back in to read this article
If you are not currently a subscriber please see contact details below